Skip to main content
. Author manuscript; available in PMC: 2013 Nov 4.
Published in final edited form as: Bioorg Med Chem. 2011 Feb 2;19(6):10.1016/j.bmc.2011.01.060. doi: 10.1016/j.bmc.2011.01.060

Table 1.

Inhibitory potencies of 9-amido analogs (5-7) for mCD22 and hCD22.

Compd. Activity
mCD227 hCD22

IC50 (μM)a rIPb IC50 (μM) rIP
1 3.84 ± 0.32 1 0.90 ± 0.00 1
5 0.10 ± 0.00 38.4 0.13 ± 0.00 7
6 0.19 ± 0.00 20.2 0.07 ± 0.01 12
7 5.00 ± 0.6 0.77 ND
a

Sialoside concentration which leads to 50% inhibition of binding. The values are the mean ± SD of triplicates.

b

The rIP of each sialoside was calculated by dividing the IC50 of the reference compound 1 by the IC50 of the compound of interest. The results in rIPs above 1.0 for derivatives binding better than the reference and rIPs below 1.0 for compounds with a lower affinity than the reference.

ND; not determined. The values for mCD22 and hCD22 cannot be directly compared